Skip to content

Clinical study protocol of rice protein peptide to improve protein malnutrition in hemodialysis patients

Clinical study protocol of rice protein peptide to improve protein malnutrition in hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068912
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Interventions

Experimental group:treat with rice protein peptide for 21 days
Control group:treat with treat with whey protein for 21 days

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged range from 18 to 90 years, no gender limit; 2. Patients diagnosed with hemodialysis; 3. Patient 28g/L<= serum albumin <=40g/L or prealbumin <=150mg/L; 4. The patient met the diagnosis of sarcopenia (walk test <0.8m/s, grip strength <25kg in men and <18kg in women or relative skeletal muscle mass index RSMI less than 7.26kg/m^2 in men and 5.45 kg/m^2 in women); 5. Be able to understand the purpose of the trial, participate voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic to the ingredients contained in the research supplies; 2. Suffering from other serious systemic diseases (such as cardiovascular, respiratory, digestive, nervous, endocrine, reproductive or other urinary system diseases, tumors, etc.); 3. Patients who suffer from mental illness, including severe hysteria, and do not have autonomous ability; 4. A history of substance abuse or alcoholism; 5. Participate in other drug clinical trials within 30 days prior to this study; 6. The researcher judged that the patient had poor compliance and could not complete the study as required.

Design outcomes

Primary

MeasureTime frame
albumin;prealbumin;IL-1;IL-6;TNF-a;body composition;the power of gripping;

Secondary

MeasureTime frame
liver function: ALT, AST;

Countries

China

Contacts

Public ContactZheng Xuan

Shanghai Changhai Hospital

15921811369@163.com+86 159 2181 1369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026